Merck Cozaar Will Get Stroke Risk Reduction Claim – FDA’s Temple

Merck Cozaar data from the LIFE study support a risk reduction claim for strokes rather than a broader new indication, FDA Office of Medical Policy Director Robert Temple, MD, said